Abstract:Conjugated linoleic acids(CLA), a group of fatty acids with conjugated double bonds, are produced by rumen microbes and stored in mammary gland, adipose, and muscle tissues in ruminants. Among CLA isomers,cis9 trans11 CLA and trans10 cis 12 CLA account for the highest proportions: cis-9, trans-11 CLA exhibits antiinflammatory and anti-cancer activities, while trans-10, cis-12 CLA plays a role in fat reduction. CLA has been recognized as a functional food component, and the U.S. Food and Drug Administration(FDA) recommends a daily intake of 3.4-6.0 g CLA for humans. Ruminant meat and dairy products contain higher CLA concentrations than other food sources. CLA exerts a primary effect on reducing fat deposition, as trans-10, cis-12 CLA exhibits higher bioactivity in regulating lipid metabolism than cis-9, trans-11 CLA. Previous studies have demonstrated that CLA supplementation reduces milk fat content, improves energy balance, and decreases disease incidence in lactating cows. Consequently, CLA supplementation has been applied as a feeding strategy for lactating cows. Although numerous studies on CLA-mediated fat deposition reduction have been published in recent years, the regulatory mechanism underlying CLA-mediated lipid metabolism remains unclear. This study reviews relevant research findings, identifies candidate genes affected by CLA, and provides references for exploring the regulatory mechanisms of CLA and expanding its application fields.